首页 > 最新文献

Cardio-oncology最新文献

英文 中文
The impact of acute coronary syndrome on long-term survival in cancer patients. 急性冠脉综合征对癌症患者长期生存的影响。
IF 3.2 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-02-07 DOI: 10.1186/s40959-026-00451-9
Daniel Finke, Markus B Heckmann, Jessica M Schug, Lukas F Entenmann, Hauke Hund, Hugo A Katus, Norbert Frey, Lorenz H Lehmann
{"title":"The impact of acute coronary syndrome on long-term survival in cancer patients.","authors":"Daniel Finke, Markus B Heckmann, Jessica M Schug, Lukas F Entenmann, Hauke Hund, Hugo A Katus, Norbert Frey, Lorenz H Lehmann","doi":"10.1186/s40959-026-00451-9","DOIUrl":"https://doi.org/10.1186/s40959-026-00451-9","url":null,"abstract":"","PeriodicalId":9804,"journal":{"name":"Cardio-oncology","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2026-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146131440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes in circulating miR-199a, cardiac troponin I, NT-proBNP, and left ventricular ejection fraction during anthracycline therapy in breast cancer patients. 蒽环类药物治疗期间乳腺癌患者循环miR-199a、心肌肌钙蛋白I、NT-proBNP和左心室射血分数的变化
IF 3.2 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-02-04 DOI: 10.1186/s40959-026-00448-4
Shaghayegh Kamian, Payam Azadeh, Robab Anbiaee, Ahmad Mafi, Hasan Ashoori, Hamed Ghoshouni, Mohammad Javad Bahadori, Tannaz Malakouti
{"title":"Changes in circulating miR-199a, cardiac troponin I, NT-proBNP, and left ventricular ejection fraction during anthracycline therapy in breast cancer patients.","authors":"Shaghayegh Kamian, Payam Azadeh, Robab Anbiaee, Ahmad Mafi, Hasan Ashoori, Hamed Ghoshouni, Mohammad Javad Bahadori, Tannaz Malakouti","doi":"10.1186/s40959-026-00448-4","DOIUrl":"https://doi.org/10.1186/s40959-026-00448-4","url":null,"abstract":"","PeriodicalId":9804,"journal":{"name":"Cardio-oncology","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146117483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Two types amyloid infiltration of the heart: diagnostic challenges and therapeutic strategies. 两种类型的心脏淀粉样蛋白浸润:诊断挑战和治疗策略。
IF 3.2 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-27 DOI: 10.1186/s40959-025-00430-6
Raúl Ramos-Polo, Santiago Jiménez-Marrero, Herminio Morillas, Alexandra Pons-Riverola, Alberto Garay, Itziar Carro, Laura Maria Gràcia, Núria Baixeras, Jesús Sánchez-Vega, Pedro Moliner
{"title":"Two types amyloid infiltration of the heart: diagnostic challenges and therapeutic strategies.","authors":"Raúl Ramos-Polo, Santiago Jiménez-Marrero, Herminio Morillas, Alexandra Pons-Riverola, Alberto Garay, Itziar Carro, Laura Maria Gràcia, Núria Baixeras, Jesús Sánchez-Vega, Pedro Moliner","doi":"10.1186/s40959-025-00430-6","DOIUrl":"https://doi.org/10.1186/s40959-025-00430-6","url":null,"abstract":"","PeriodicalId":9804,"journal":{"name":"Cardio-oncology","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146060624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diabetes and cancer: therapeutic implications. 糖尿病和癌症:治疗意义。
IF 3.2 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-23 DOI: 10.1186/s40959-025-00412-8
Stavros Fay, Gabriella Bayshtok, Carine E Hamo, Javed Butler, Michelle Bloom
{"title":"Diabetes and cancer: therapeutic implications.","authors":"Stavros Fay, Gabriella Bayshtok, Carine E Hamo, Javed Butler, Michelle Bloom","doi":"10.1186/s40959-025-00412-8","DOIUrl":"https://doi.org/10.1186/s40959-025-00412-8","url":null,"abstract":"","PeriodicalId":9804,"journal":{"name":"Cardio-oncology","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146040642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiovascular risk factors and cardiac dysfunction in people with HIV and breast cancer: an observational cohort study in Botswana. 艾滋病毒和乳腺癌患者的心血管危险因素和心功能障碍:博茨瓦纳的一项观察性队列研究
IF 3.2 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-22 DOI: 10.1186/s40959-025-00417-3
Henrietta Afari, Congying Xia, Julius Mwita, Thato Moshomo, Anran Huang, Maliha Shaikh, Sebaga W Motlhwa, Tlotlo Ralefala, Peter Vuylsteke, Scott Dryden-Peterson, Priscilla Y Hsue, Robert Gross, Mosepele Mosepele, Bonnie Ky, Yehoda M Martei

Background: HIV, cancer, and their respective treatments are independently associated with cardiovascular risk, but limited data exist on the intersection of these conditions. The purpose of this study was to gain insights into the cardiovascular risk factor burden and cardiac function in people with HIV (PWH) treated for breast cancer.

Methods: In a cohort of PWH and breast cancer treated with anthracyclines and/or trastuzumab (2017-2022) in Botswana, we assessed pre-treatment (baseline) left ventricular ejection fraction (LVEF), and prospectively obtained an echocardiogram at least one year after cancer treatment initiation. Wilcoxon signed rank sum test was used to test the differences between baseline and follow-up LVEF.

Results: Thirty-three women were enrolled at a median of 2.1 years (Quartile (Q)1-Q3 1.8-3.1) from their cancer treatment initiation. The median age was 48.0 years (Q1-Q3 44.0-54.0). All but one patient was on antiretroviral therapy (ART); the median ART duration was 11.6 years (Q1-Q3 6.3-15 years) with a median viral load of 30 (Q1-Q3 0-30) and CD4 count of 874 (Q1-Q3 361-1131). At baseline, 70% were obese or overweight, and 24.2% reported hypertension; this increased to 30.3% at follow-up. The median LVEF at baseline was 65% (Q1-Q3 60-68%), and decreased to 62% (Q1-Q3 59-65%) at follow-up; an absolute difference of 2.9%, 95%CI: -5.3 to -0.2% (p = 0.038). There was no report of clinical heart failure.

Conclusions: Obesity and hypertension are highly prevalent amongst PWH and breast cancer. We also noted a statistically significant, but modest decline in LVEF after cancer therapy initiation. Further studies are needed to prospectively characterize the cardiovascular risk factor burden and changes in cardiac structure and function following cardiotoxic cancer treatment in this population.

背景:艾滋病毒、癌症及其各自的治疗与心血管风险独立相关,但关于这些疾病交叉的数据有限。本研究的目的是深入了解接受乳腺癌治疗的HIV感染者(PWH)的心血管危险因素负担和心功能。方法:在博茨瓦纳接受蒽环类药物和/或曲妥珠单抗治疗的PWH和乳腺癌队列(2017-2022)中,我们评估了治疗前(基线)左心室射血分数(LVEF),并在癌症治疗开始后至少一年后前瞻性地获得超声心动图。采用Wilcoxon符号秩和检验检验基线与随访LVEF的差异。结果:33名妇女入组,中位数为2.1年(四分位数(Q)1-Q3 1.8-3.1),从她们的癌症治疗开始。中位年龄为48.0岁(Q1-Q3 44.0-54.0岁)。除一名患者外,所有患者都在接受抗逆转录病毒治疗(ART);中位ART持续时间为11.6年(Q1-Q3 6.3-15年),中位病毒载量为30 (Q1-Q3 0-30), CD4计数为874 (Q1-Q3 361-1131)。基线时,70%的人肥胖或超重,24.2%的人有高血压;在随访中增加到30.3%。基线时中位LVEF为65% (Q1-Q3 60-68%),随访时降至62% (Q1-Q3 59-65%);绝对差异为2.9%,95%CI: -5.3 ~ -0.2% (p = 0.038)。没有临床心力衰竭的报告。结论:肥胖和高血压在PWH和乳腺癌中非常普遍。我们还注意到,在癌症治疗开始后,LVEF有统计学意义但适度的下降。需要进一步的研究来前瞻性地描述心血管危险因素负担以及心脏毒性癌症治疗后心脏结构和功能的变化。
{"title":"Cardiovascular risk factors and cardiac dysfunction in people with HIV and breast cancer: an observational cohort study in Botswana.","authors":"Henrietta Afari, Congying Xia, Julius Mwita, Thato Moshomo, Anran Huang, Maliha Shaikh, Sebaga W Motlhwa, Tlotlo Ralefala, Peter Vuylsteke, Scott Dryden-Peterson, Priscilla Y Hsue, Robert Gross, Mosepele Mosepele, Bonnie Ky, Yehoda M Martei","doi":"10.1186/s40959-025-00417-3","DOIUrl":"10.1186/s40959-025-00417-3","url":null,"abstract":"<p><strong>Background: </strong>HIV, cancer, and their respective treatments are independently associated with cardiovascular risk, but limited data exist on the intersection of these conditions. The purpose of this study was to gain insights into the cardiovascular risk factor burden and cardiac function in people with HIV (PWH) treated for breast cancer.</p><p><strong>Methods: </strong>In a cohort of PWH and breast cancer treated with anthracyclines and/or trastuzumab (2017-2022) in Botswana, we assessed pre-treatment (baseline) left ventricular ejection fraction (LVEF), and prospectively obtained an echocardiogram at least one year after cancer treatment initiation. Wilcoxon signed rank sum test was used to test the differences between baseline and follow-up LVEF.</p><p><strong>Results: </strong>Thirty-three women were enrolled at a median of 2.1 years (Quartile (Q)1-Q3 1.8-3.1) from their cancer treatment initiation. The median age was 48.0 years (Q1-Q3 44.0-54.0). All but one patient was on antiretroviral therapy (ART); the median ART duration was 11.6 years (Q1-Q3 6.3-15 years) with a median viral load of 30 (Q1-Q3 0-30) and CD4 count of 874 (Q1-Q3 361-1131). At baseline, 70% were obese or overweight, and 24.2% reported hypertension; this increased to 30.3% at follow-up. The median LVEF at baseline was 65% (Q1-Q3 60-68%), and decreased to 62% (Q1-Q3 59-65%) at follow-up; an absolute difference of 2.9%, 95%CI: -5.3 to -0.2% (p = 0.038). There was no report of clinical heart failure.</p><p><strong>Conclusions: </strong>Obesity and hypertension are highly prevalent amongst PWH and breast cancer. We also noted a statistically significant, but modest decline in LVEF after cancer therapy initiation. Further studies are needed to prospectively characterize the cardiovascular risk factor burden and changes in cardiac structure and function following cardiotoxic cancer treatment in this population.</p>","PeriodicalId":9804,"journal":{"name":"Cardio-oncology","volume":"12 1","pages":"9"},"PeriodicalIF":3.2,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12829206/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146028190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Macrophage surface protein Mac-2 mediates inflammatory and stromal stress pathways in doxorubicin-induced cardiac injury. 巨噬细胞表面蛋白Mac-2介导阿霉素诱导心脏损伤的炎症和基质应激途径。
IF 3.2 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-22 DOI: 10.1186/s40959-026-00443-9
Swati D Sonkawade, Lee D Chavez, Shirley Xu, Xiaoyi Ma, Sarmila Nepali, Steven E Lipshultz, Saraswati Pokharel, Umesh C Sharma
{"title":"Macrophage surface protein Mac-2 mediates inflammatory and stromal stress pathways in doxorubicin-induced cardiac injury.","authors":"Swati D Sonkawade, Lee D Chavez, Shirley Xu, Xiaoyi Ma, Sarmila Nepali, Steven E Lipshultz, Saraswati Pokharel, Umesh C Sharma","doi":"10.1186/s40959-026-00443-9","DOIUrl":"https://doi.org/10.1186/s40959-026-00443-9","url":null,"abstract":"","PeriodicalId":9804,"journal":{"name":"Cardio-oncology","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146028003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Statin initiation among cancer survivors with asymptomatic coronary atherosclerosis. 无症状冠状动脉粥样硬化的癌症幸存者开始使用他汀类药物。
IF 3.2 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-19 DOI: 10.1186/s40959-025-00428-0
Cheng Hwee Soh, Shristy Shrestha, Kristyn Whitmore, Batsheva Greenbaum, Atro Azad, Melinda J Carrington, Joel Smith, Thomas H Marwick
{"title":"Statin initiation among cancer survivors with asymptomatic coronary atherosclerosis.","authors":"Cheng Hwee Soh, Shristy Shrestha, Kristyn Whitmore, Batsheva Greenbaum, Atro Azad, Melinda J Carrington, Joel Smith, Thomas H Marwick","doi":"10.1186/s40959-025-00428-0","DOIUrl":"https://doi.org/10.1186/s40959-025-00428-0","url":null,"abstract":"","PeriodicalId":9804,"journal":{"name":"Cardio-oncology","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146003088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between polygenic risk scores and cardiovascular events in prostate cancer patients receiving androgen deprivation therapy in Han Chinese. 汉族接受雄激素剥夺治疗的前列腺癌患者多基因风险评分与心血管事件的关系
IF 3.2 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-16 DOI: 10.1186/s40959-026-00445-7
Qun-Yi Nian, Li-Wen Chang, Hui-Wen Yang, Jian-Ri Li, Sheng-Chun Hung, I-Chieh Chen
{"title":"Association between polygenic risk scores and cardiovascular events in prostate cancer patients receiving androgen deprivation therapy in Han Chinese.","authors":"Qun-Yi Nian, Li-Wen Chang, Hui-Wen Yang, Jian-Ri Li, Sheng-Chun Hung, I-Chieh Chen","doi":"10.1186/s40959-026-00445-7","DOIUrl":"https://doi.org/10.1186/s40959-026-00445-7","url":null,"abstract":"","PeriodicalId":9804,"journal":{"name":"Cardio-oncology","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145988479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardioprotective effect of diabetic medication on cancer patients undergoing proven cardiotoxic chemotherapy: a systematic review and meta-analysis. 糖尿病药物对接受心脏毒性化疗的癌症患者的心脏保护作用:系统回顾和荟萃分析。
IF 3.2 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-15 DOI: 10.1186/s40959-025-00424-4
Abdelrahman El-Helbawy, Sara T Zaki, Fouad Hanna, Mohamed Bassiouni, Khaled O Yaseen, Amany H Ali, Oliver M Farid
{"title":"Cardioprotective effect of diabetic medication on cancer patients undergoing proven cardiotoxic chemotherapy: a systematic review and meta-analysis.","authors":"Abdelrahman El-Helbawy, Sara T Zaki, Fouad Hanna, Mohamed Bassiouni, Khaled O Yaseen, Amany H Ali, Oliver M Farid","doi":"10.1186/s40959-025-00424-4","DOIUrl":"10.1186/s40959-025-00424-4","url":null,"abstract":"","PeriodicalId":9804,"journal":{"name":"Cardio-oncology","volume":" ","pages":"14"},"PeriodicalIF":3.2,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12853835/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145988424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abemaciclib-induced myocarditis in early breast cancer: a case report. abemaciclib致早期乳腺癌心肌炎1例报告。
IF 3.2 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-01-14 DOI: 10.1186/s40959-025-00442-2
Alexander Jp Fulton, Mun Cheang, Maria Ta Wetscherek, Paul Cacciottolo, Jean E Abraham
{"title":"Abemaciclib-induced myocarditis in early breast cancer: a case report.","authors":"Alexander Jp Fulton, Mun Cheang, Maria Ta Wetscherek, Paul Cacciottolo, Jean E Abraham","doi":"10.1186/s40959-025-00442-2","DOIUrl":"https://doi.org/10.1186/s40959-025-00442-2","url":null,"abstract":"","PeriodicalId":9804,"journal":{"name":"Cardio-oncology","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145970660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cardio-oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1